KA
GERN icon

Kozak & Associates’s Geron GERN Stock Holding History

Kozak & Associates’s Portfolio GERN Stock Details GERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100
Closed -$197 – 410
2023
Q4 		$197 Buy
+100
New +$194 ﹤0.01% 351

Other funds holding GERN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kozak & Associates's GERN Position: Q1 2024 in Review

Kozak & Associates sold out of Geron (GERN) in Q1 2024, closing a stake of 100 shares — an estimated $197 sold.

Kozak & Associates first reported a position in GERN in Q4 2023 and held it in 1 quarter. The position peaked at $197 in Q4 2023. 231 funds tracked by Wall St. Rank hold GERN as of Q1 2024.

  • Kozak & Associates reported no remaining Geron position as of Q1 2024 after selling out during the quarter.
  • Kozak & Associates sold 100 Geron shares in Q1 2024, an estimated $197.
  • Kozak & Associates first reported a position in Geron in Q4 2023 and held it in 1 quarter.
  • Kozak & Associates's Geron position peaked at $197 in Q4 2023.
  • 231 funds tracked by Wall St. Rank held Geron as of Q1 2024.

Based on Kozak & Associates's 13F filing for Q1 2024, filed 17 May 2024.